Warfarin or dabigatran for treatment of atrial fibrillation

Journal of Thrombosis and Haemostasis

Volumn 12, Issue 7, 2014, Pages 1193-1195

  Poller, L ^a   Jespersen, J ^b   Ibrahim, S ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Clinical trial; Dabigatran; International normalized ratio; Thrombosis; Warfarin

Indexed keywords

DABIGATRAN; WARFARIN; ANTICOAGULANT AGENT; BENZIMIDAZOLE DERIVATIVE; BETA ALANINE;

ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; BLEEDING; DRUG EFFICACY; DRUG SAFETY; EVALUATION STUDY; HEART ATRIUM FIBRILLATION; HUMAN; PRIORITY JOURNAL; AGED; ANALOGS AND DERIVATIVES; ATRIAL FIBRILLATION; CLINICAL TRIAL; COMPUTER PROGRAM; CONTROLLED STUDY; EUROPE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; THROMBOEMBOLISM;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; BENZIMIDAZOLES; BETA-ALANINE; EUROPE; HEMORRHAGE; HUMANS; SOFTWARE; THROMBOEMBOLISM; WARFARIN;

EID: 84904292696     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12590     Document Type: Article

References (17)

1. Poller L, Keown M, Ibrahim S, Lowe G, Moia M, Turpie AG, Roberts C, van den Besselaar AMHP, van der Meer FJM, Tripodi A, Palareti G, Shiach C, Bryan S, Samama M, Burgess-Wilson M, Heagerty A, MacCallum P, Wright D, Jespersen J. An international multicentre study of computer assisted oral anticoagulant dosage versus medical staff. J Thromb Haemost 2008; 6: 935-43.
2. van den Besselaar AHMP, Tripodi A, Poller L. Guidelines for thromboplastin and plasmas used to control oral anticoagulant therapy. World Health Organ Tech Rep Ser 1999; 889: 64-93.
3. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L, the RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139-51.
4. Poller L, Ibrahim S, Keown M, Pattison A, Jespersen J. Simplified method for international normalised ratio (INR) derivation based on the prothrombin time/INR Line. An International Study. Clin Chem 2010; 56: 1608-17.
5. Poller L, Ibrahim S, Keown M, Pattison A, Jespersen J. European Action on anticoagulation. The prothrombin time /international normalized ratio (PT/INR) Line: derivation of local INR with commercial thromboplastins and coagulometers - two independent studies. J Thromb Haemost 2011; 9: 140-8.
6. Ibrahim S, Jespersen J, Pattison A, Poller L, on behalf of the European Concerted Action on anticoagulation. Evaluation of European Concerted Action on Anticoagulation lyophilized plasmas for INR derivation using the PT/INR Line. Am J Clin Pathol 2011; 135: 732-40.
7. Poller L, Jespersen J. Editorial: Local international normalised ratio (INR) derivation simplified using the European Concerted Action on Anticoagulation (ECAA) prothrombin time/INR Line. Thromb Res 2011; 128: 101-2.
8. Poller L, Ibrahim S, Jespersen J, Pattison A. Coagulometer international sensitivity index derivation, a rapid method using the prothrombin time/international normalised ratio (PT/INR) Line: a multicentre study. J Thromb Haemost 2012; 10: 1379-84.
9. Ibrahim S, Jespersen J, Poller L. The clinical evaluation of INR variability and control in conventional oral anticoagulant administration using the variance growth rate. J Thromb Haemost 2013; 11: 1540-6.
10. Poller L. Standardization of anticoagulant treatment: the Manchester regional thromboplastin scheme. Br Med J 1964; 2: 565-6.
11. Poller L. A national standard for anticoagulant therapy. The Manchester comparative reagent. Lancet 1967; 1: 491-3.
12. Poller L, Thomson JM, Taberner DA, Clarke DK. The correction of coagulometer effects on international normalized ratios: a multicentre evaluation. Br J Haematol 1994; 86: 112-7.
13. Poller L, Hirsh J. Laboratory monitoring of anticoagulants. In: Poller L, Hirsh J, eds. Oral Anticoagulants. London, UK: Arnold, 1996: 49-64.
14. Poller L, Ibrahim S, Pattison A, Jespersen J. INR derivation with the PT/INR Line simplified using a spreadsheet from the world- wide web. J Clin Pathol 2011; 64: 930-2.
15. ESC-Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease. Vitamin K antagonists in heart disease: current status and perspectives (section III). Thromb Haemost 2013; 110: 1087-107.
16. Fihn SD, McDonell M, Martin D, Henikoff J, Vermes D, Kent D, White RH. Risk factors for complications of chronic anticoagulation: a multicenter study. Ann Intern Med 1993; 118: 511-20.
17. Fihn SD, Callahan CM, Martin DC, McDonell MB, Henikoff JG, White RH. The risk for and severity of bleeding complications in elderly patients treated with warfarin. Ann Intern Med 1996; 124: 970-9.